Evidence map›Paper›PMID 42316006›Full record

ArticleBMC genomics2026

Widespread genetic testing controls inherited polycystic kidney disease while avoiding inbreeding in cats.

Hisashi Ukawa, Akane Kida, Kai Ataka, Ryo Horie, Yuki Matsumoto

Abstract read
In one paragraph

Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hisashi UkawaGenetic Testing Section, Anicom Pafe Inc, 2-6-3 Chojamachi, Kanagawa, Yokohamashi-Nakaku, 231-0033, Japan.
Akane KidaResearch and Development Section, Anicom Insurance Inc, 8-17-1 Nishi-Shinjuku, Tokyo, Shinjuku-ku, 160-0023, Japan.
Kai AtakaGenetic Testing Section, Anicom Pafe Inc, 2-6-3 Chojamachi, Kanagawa, Yokohamashi-Nakaku, 231-0033, Japan.
Ryo HorieResearch and Development Section, Anicom Insurance Inc, 8-17-1 Nishi-Shinjuku, Tokyo, Shinjuku-ku, 160-0023, Japan.
Yuki MatsumotoGenetic Testing Section, Anicom Pafe Inc, 2-6-3 Chojamachi, Kanagawa, Yokohamashi-Nakaku, 231-0033, Japan. y-matsumoto@azabu-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPolycystic kidney disease (PKD) is a major hereditary disorder characterized by the formation of cysts in the kidneys of mammals, including humans and cats. It commonly leads to renal failure and is frequently associated with variants in the PKD1 gene. In cats, a specific PKD1 variant (chr E3:g.42858112 C > A) is a primary target for direct-to-consumer (DTC) genetic testing aimed at identifying PKD risk. However, its broad impact on the genetic structure of cat populations remains unclear. In this study, we investigated temporal and breed-specific dynamics of feline PKD and the PKD1 variant using a large-scale dataset comprising 110,325 insured cats and 61,968 genetically tested cats across 14 breeds in Japan.

resultsOur comprehensive analysis of insured cats revealed no clear differences in claim-based detection of cystic kidneys across breeds, sexes, or ages, although notable geographic variations were observed. Among the cats diagnosed with cystic kidneys, 77.8% carried the conventional PKD1 variant. Exome and whole-genome sequencing of affected cats revealed eight potentially deleterious variants in PKD-related genes, suggesting the involvement of other genetic factors. The carrier frequency of the PKD1 variant in all 14 breeds decreased by 42.6% when comparing genetic data from 2019, when full-scale genetic testing for kittens began, and 2022. In additional analyses focusing on eight breeds with larger sample sizes, significant reductions in the proportion of heterozygous cats were observed in Scottish Folds, Persians, and Ragamuffins (49.5%, 38.8%, and 57.7% decrease, respectively) between the two time points. In contrast, no statistically significant or suggestive reductions were observed in British Shorthairs, Minuets, or Munchkins. Further genomic analyses in Scottish Folds and Persians indicated no substantial changes in overall genetic structure or inbreeding levels; however, the effective population size of cats harboring the PKD1 variant declined between these periods.

conclusionsThese findings highlight the role of DTC genetic testing in promoting optimized breeding strategies that contribute to reducing PKD risk while avoiding inbreeding and enhancing feline welfare. To further reduce the number of risk variants, promoting genetic testing and ensuring appropriate breeding practices is necessary, particularly for breeds in which a decrease in PKD1 variants has not been observed.

Indexed as

Cat DiseasesGenetic TestingInbreedingPolycystic Kidney DiseasesAnimalsCatsFemaleGenetic Predisposition to DiseaseMaleTRPP Cation ChannelsTRPP Cation ChannelsCatGenetic testingPolycystic kidney disease

Identifiers

PMID42316006
PMCPMC13520345

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.